BioBos IBR marker live, Lyophilisate for suspension
BioBos IBR marker live, Lyophilisate for suspension
Authorised
- Infectious Bovine rhinotracheitis virus, strain BIO-27, Live
Product identification
Medicine name:
BioBos IBR marker live, Lyophilisate for suspension
BioBos IBR marker live lyofilizát a rozpúšťadlo na suspenziu
Active substance:
- Infectious Bovine rhinotracheitis virus, strain BIO-27, Live
Target species:
-
Cattle
Route of administration:
-
Nasal use
-
Intramuscular use
Product details
Active substance and strength:
-
Infectious Bovine rhinotracheitis virus, strain BIO-27, Live7.50log10 tissue culture infective dose 501.00Dose
Pharmaceutical form:
-
Lyophilisate for suspension
Withdrawal period by route of administration:
-
Nasal use
- Cattle
-
Meat and offal0day
-
-
Intramuscular use
- Cattle
-
Milk0hour
-
Meat and offal0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI02AD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Slovakia
Package description:
- Glass Vial 1 x 25.0 Dose
- Glass Vial 5 x 5.0 Dose
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
- 97/024/MR/17-S
Date of authorisation status change:
Reference member state:
-
Czechia
Procedure number:
- CZ/V/0137/001
Concerned member states:
-
Bulgaria
-
Croatia
-
Cyprus
-
Estonia
-
Greece
-
Hungary
-
Latvia
-
Romania
-
Slovakia
-
Slovenia
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 2/03/2022
How useful was this page?: